92nd General Assembly Summary of HB1807    [ Home ]   [ Back ]   [ Legislation ]

Legislation:   Please enter a bill number.

House Sponsors:
ZICKUS-FEIGENHOLTZ-COULSON-HAMOS-DELGADO AND WOJCIK.

Senate Sponsors:
RAUSCHENBERGER-RADOGNO

Short description: 
IDPH-MEDICAID-OBESITY PROGRAM                                              

Synopsis of Bill as introduced:
        Creates the Anti-Obesity and Related  Comorbidities  Therapy  Act      
   and  amends  the Illinois Public Aid Code.  Requires the Department of      
   Public Health,  in conjunction with  the Department of  Public Aid and      
   other agencies,  to  develop  a program  to provide  obese or  at-risk      
   overweight medically indigent patients with services for the treatment      
   and prevention of  obesity and its related comorbidities. Provides for      
   coverage  of  the  program   services  under   Medicaid.     Effective      
   immediately.                                                                
          FISCAL NOTE (Department of Public Aid)                               
          The Department estimates the cost to be between $105 million         
          and $210 million annually.                                           
        HOUSE AMENDMENT NO. 1.                                                 
        In  the  Anti-Obesity  and  Related  Comorbidities  Therapy  Act,      
   deletes   gallbladder   disease,   gastric   reflux   disease,   gout,      
   infertility, osteoarthritis of the  hips  or  knees,  and  respiratory      
   difficulties from the list of comorbidities in the definition of            
   "at-risk overweight". In the amendatory changes to the Illinois Public      
   Aid Code, provides for Medicaid coverage of services for the treatment      
   and prevention of obesity and its related comorbidities if a patient        
   is otherwise eligible for Medicaid (instead of requiring the                
   Department of Public Aid to provide those services to Medicaid              
   recipients who participate in the program developed by the Department       
   of Public Health under the Anti-Obesity and Related Comorbidities           
   Therapy Act).                                                               
          FISCAL NOTE, H-AM 1 (Department of Public Aid)                       
          The Department estimates the cost to be $3,333.08 per person         
          per year ($1.188 per capsulex90 capsules perx12 months+$4.17         
          dispensing feex12): if 1% of the average Medicaid monthly pop-       
          ulation (14,000 people) qualified for these drugs the estimated      
          cost is $18,663,120 per year.                                        
 
Last action on Bill: SESSION SINE DIE

   Last action date: JAN-07-2003

           Location: House

 Amendments to Bill: AMENDMENTS ADOPTED: HOUSE -   1     SENATE -   0


   END OF INQUIRY 


 Full Text  Bill Status